Ai Virtual Agent Selection, Implementation and Support Keys to Success
Improving Population Health via Non-traditional Partnerships
Efficient Data Management in the Healthcare Space
Transform Healthcare with a Passion for Innovation
Significant technological change often means a cultural shift for...
NovletMattis, Chief Information Officer, Orlando Health
Disrupting the CIO Comfort Zone to Innovate and Transform How...
Wes Williams, VP & CIO, Mental Health Center Of Denver
Bringing the Worlds of Technology and Health Closer to Each Other
Kristin Myers, Chief Information Officer, Mount Sinai Health System
The Biopsychosocial Model: The Future of Remote Patient Monitoring
Heather Comerci Reyes, Md, Me; Michael Hasselberg, Phd, Chief Digital Health Officer, University Of Rochester Medical Center
Thank you for Subscribing to CIO Applications Weekly Brief
Calyx EDC Selected for RWE Data Collection in Extensive Late-Phase Trial
Calyx transforms the uncertain into the reliable through innovative eClinical and Regulatory solutions and services, assisting in the timely introduction of new medical treatments to the market
Fremont, CA: A leading pharmaceutical company had chosen Calyx's electronic data capture (EDC) system to capture Real World Evidence (RWE) data for a global, late-phase study.
The global company chose calyx EDC because of its proven effectiveness in capturing critical patient data during lengthy, international studies. In addition, calyx's ability to promptly deliver a dependable, cost-effective solution to meet the pharmaceutical company's accelerated study timelines and continuous data collection requirements was critical in its selection.
"We're thrilled to be working with this leading pharmaceutical company and to extend our 30 years of experience in delivering reliable, high-quality data to help them fully understand the long-term effects of their medical products," said Juan Munoz-Pujol, Calyx's Vice President, IRT, and EDC.